BDRX
Price
$0.87
Change
-$0.06 (-6.45%)
Updated
Jun 27 closing price
Capitalization
4.39M
FHTX
Price
$4.84
Change
-$0.02 (-0.41%)
Updated
Jun 27 closing price
Capitalization
269.79M
43 days until earnings call
Interact to see
Advertisement

BDRX vs FHTX

Header iconBDRX vs FHTX Comparison
Open Charts BDRX vs FHTXBanner chart's image
Biodexa Pharmaceuticals
Price$0.87
Change-$0.06 (-6.45%)
Volume$274.78K
Capitalization4.39M
Foghorn Therapeutics
Price$4.84
Change-$0.02 (-0.41%)
Volume$870.13K
Capitalization269.79M
BDRX vs FHTX Comparison Chart in %
Loading...
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDRX vs. FHTX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDRX is a Buy and FHTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BDRX: $0.87 vs. FHTX: $4.84)
Brand notoriety: BDRX and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDRX: 13% vs. FHTX: 652%
Market capitalization -- BDRX: $4.39M vs. FHTX: $269.79M
BDRX [@Biotechnology] is valued at $4.39M. FHTX’s [@Biotechnology] market capitalization is $269.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDRX’s FA Score shows that 1 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • BDRX’s FA Score: 1 green, 4 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BDRX and FHTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDRX’s TA Score shows that 3 TA indicator(s) are bullish while FHTX’s TA Score has 4 bullish TA indicator(s).

  • BDRX’s TA Score: 3 bullish, 4 bearish.
  • FHTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than BDRX.

Price Growth

BDRX (@Biotechnology) experienced а -15.53% price change this week, while FHTX (@Biotechnology) price change was +2.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.67%. For the same industry, the average monthly price growth was +32.94%, and the average quarterly price growth was +6.79%.

Reported Earning Dates

FHTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+3.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($270M) has a higher market cap than BDRX($4.39M). FHTX YTD gains are higher at: 2.542 vs. BDRX (-78.519).
BDRXFHTXBDRX / FHTX
Capitalization4.39M270M2%
EBITDAN/A-91.89M-
Gain YTD-78.5192.542-3,088%
P/E RatioN/AN/A-
RevenueN/A23.5M-
Total CashN/A221M-
Total DebtN/A34.9M-
FUNDAMENTALS RATINGS
BDRX: Fundamental Ratings
BDRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDRXFHTX
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLY38.910.13
+0.34%
Ally Financial
UHT40.11N/A
N/A
Universal Health Realty Income Trust
INDB63.63-0.07
-0.11%
Independent Bank Corp
FFAI1.47-0.06
-3.92%
Faraday Future Intelligent Electric Inc
LPSN0.93-0.04
-4.14%
LivePerson

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with GTBP. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then GTBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
-6.21%
GTBP - BDRX
39%
Loosely correlated
N/A
ATNF - BDRX
37%
Loosely correlated
-4.27%
FHTX - BDRX
34%
Loosely correlated
-0.41%
KRRO - BDRX
33%
Poorly correlated
-3.16%
SCNI - BDRX
32%
Poorly correlated
-7.69%
More

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ABOS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-0.41%
ABOS - FHTX
54%
Loosely correlated
-7.44%
IPSC - FHTX
49%
Loosely correlated
-5.74%
IMNM - FHTX
48%
Loosely correlated
-0.23%
CRSP - FHTX
48%
Loosely correlated
N/A
NAUT - FHTX
47%
Loosely correlated
-12.57%
More